Clinical and experimental rheumatology最新文献

筛选
英文 中文
Should multisystem inflammatory syndrome in children be considered occult macrophage activation syndrome? 儿童多系统炎症综合征应被视为隐匿性巨噬细胞激活综合征吗?
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-09 DOI: 10.55563/clinexprheumatol/hc0ukd
Jung Woo Rhim, Soo-Young Lee
{"title":"Should multisystem inflammatory syndrome in children be considered occult macrophage activation syndrome?","authors":"Jung Woo Rhim, Soo-Young Lee","doi":"10.55563/clinexprheumatol/hc0ukd","DOIUrl":"https://doi.org/10.55563/clinexprheumatol/hc0ukd","url":null,"abstract":"","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145029058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to the comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis. 在系统性硬化症中,血清可溶性白介素-2受体浓度升高与高敏感性肌钙蛋白T和疾病进展有关。
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-08 DOI: 10.55563/clinexprheumatol/eaaqk8
Sebastiann Klapa, Luise Schumacher, Peter Lamprecht
{"title":"Reply to the comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis.","authors":"Sebastiann Klapa, Luise Schumacher, Peter Lamprecht","doi":"10.55563/clinexprheumatol/eaaqk8","DOIUrl":"https://doi.org/10.55563/clinexprheumatol/eaaqk8","url":null,"abstract":"","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145029040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of upadacitinib in giant cell arteritis. upadacitinib在巨细胞动脉炎中的应用。
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-08 DOI: 10.55563/clinexprheumatol/5ozvlt
Hande Ogun, Yesim Ozguler
{"title":"Use of upadacitinib in giant cell arteritis.","authors":"Hande Ogun, Yesim Ozguler","doi":"10.55563/clinexprheumatol/5ozvlt","DOIUrl":"https://doi.org/10.55563/clinexprheumatol/5ozvlt","url":null,"abstract":"","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145029010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis. 点评:血清可溶性白介素-2受体浓度升高与高敏感性肌钙蛋白T和系统性硬化症的疾病进展有关。
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-08 DOI: 10.55563/clinexprheumatol/5ynhsh
Gang Chen, Lu Mei Zhang, Yu Zhang
{"title":"Comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis.","authors":"Gang Chen, Lu Mei Zhang, Yu Zhang","doi":"10.55563/clinexprheumatol/5ynhsh","DOIUrl":"https://doi.org/10.55563/clinexprheumatol/5ynhsh","url":null,"abstract":"","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145029023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism. 评论:从依那西普或阿达木单抗原药转向生物仿制药后的反安慰剂效应评价:一项炎症性风湿病患者的回顾性研究。
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-05 DOI: 10.55563/clinexprheumatol/v0g0cd
Vicenç Torrente-Segarra, Cynthia Rojas, Maria Bonet
{"title":"Comment on: Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism.","authors":"Vicenç Torrente-Segarra, Cynthia Rojas, Maria Bonet","doi":"10.55563/clinexprheumatol/v0g0cd","DOIUrl":"https://doi.org/10.55563/clinexprheumatol/v0g0cd","url":null,"abstract":"","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond the ratios: what influences neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in paediatric systemic lupus erythematosus? 超越比率:是什么影响中性粒细胞与淋巴细胞比率和血小板与淋巴细胞比率在小儿系统性红斑狼疮?
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-02 DOI: 10.55563/clinexprheumatol/k79lo4
Fatih Demircioğlu
{"title":"Beyond the ratios: what influences neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in paediatric systemic lupus erythematosus?","authors":"Fatih Demircioğlu","doi":"10.55563/clinexprheumatol/k79lo4","DOIUrl":"https://doi.org/10.55563/clinexprheumatol/k79lo4","url":null,"abstract":"","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world outcomes of rituximab- and cyclophosphamide-based induction therapy regimens alone and in combination over 24 months in ANCA-associated vasculitis. 以利妥昔单抗和环磷酰胺为基础的诱导治疗方案单独和联合治疗anca相关血管炎超过24个月的实际结果
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-02 DOI: 10.55563/clinexprheumatol/cfyh9p
Katja von Allwörden, Sebastian Klapa, Stephan Christian Werth, Anja Leheis, Hanna Graßhoff, Antje Müller, Gabriela Riemekasten, Martin Nitschke, Diamant Thaçi, Peter Lamprecht
{"title":"Real-world outcomes of rituximab- and cyclophosphamide-based induction therapy regimens alone and in combination over 24 months in ANCA-associated vasculitis.","authors":"Katja von Allwörden, Sebastian Klapa, Stephan Christian Werth, Anja Leheis, Hanna Graßhoff, Antje Müller, Gabriela Riemekasten, Martin Nitschke, Diamant Thaçi, Peter Lamprecht","doi":"10.55563/clinexprheumatol/cfyh9p","DOIUrl":"10.55563/clinexprheumatol/cfyh9p","url":null,"abstract":"<p><strong>Objectives: </strong>This retrospective cohort study aimed to evaluate real-world data on the efficacy of rituximab (RTX) alone versus combined rituximab/cyclophosphamide (RTX/CYC) induction therapy, followed by RTX maintenance, compared with cyclophosphamide-azathioprine (CYC-AZA) therapy in ANCA-associated vasculitis (AAV).</p><p><strong>Methods: </strong>Patients with new-onset or relapsing organ- or life-threatening AAV (granulomatosis with polyangiitis [GPA] n=97; microscopic polyangiitis [MPA], n=69) were followed over 24-months. Patients with previous RTX and/or CYC therapy were excluded. Treatment comprised combination of GC with either RTX alone or RTX/CYC combination for remission induction, each followed by RTX maintenance therapy, or CYC-AZA therapy. The primary outcome measure was complete remission defined as absence of vasculitis activity with no concomitant GC therapy after 12 and 24 months.</p><p><strong>Results: </strong>20% and 35% of the patients in the RTX group and 22% and 33% in the RTX/CYC group achieved complete remission at 12 and 24 months, contrasting with 3% and 9% in the CYC-AZA group (p=0.008 and p=0.003, respectively). The majority of patients achieved remission with concomitant GC therapy at any time during the 24-months observation period (RTX, 88%; RTX/CYC, 87%; CYC-AZA, 81%; p=0.097). RTX alone was associated with a lower relapse rate compared with RTX/CYC in the subgroup of GPA patients (p=0.041). Moreover, RTX alone was comparably effective to RTX/CYC and CYC-AZA in terms of relapse in patients with severe renal disease (p=0.091).</p><p><strong>Conclusions: </strong>RTX alone was similarly effective to RTX/CYC combination and CYC-AZA therapy in AAV patients, including those with severe renal involvement.</p>","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synovial biopsy in a case of nivolumab-induced arthritis. 尼伏单抗引起的关节炎一例滑膜活检。
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-02 DOI: 10.55563/clinexprheumatol/2z7vho
Roberto Pereira da Costa, Mafalda Pinho, João Patrocínio, Sofia Torres, Cristina Ferreira, João Eurico Fonseca, Nikita Khmelinskii
{"title":"Synovial biopsy in a case of nivolumab-induced arthritis.","authors":"Roberto Pereira da Costa, Mafalda Pinho, João Patrocínio, Sofia Torres, Cristina Ferreira, João Eurico Fonseca, Nikita Khmelinskii","doi":"10.55563/clinexprheumatol/2z7vho","DOIUrl":"https://doi.org/10.55563/clinexprheumatol/2z7vho","url":null,"abstract":"","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144945132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictions of rheumatoid arthritis burden in 204 countries and territories by 2044: based on the Global Burden of Disease Study 2021. 到2044年对204个国家和地区类风湿关节炎负担的预测:基于2021年全球疾病负担研究
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-02 DOI: 10.55563/clinexprheumatol/7dijpb
Wenhao Zhang, Dongmei Zhuang, Huan Lu, Ziyan Lv, Limin Huang, He Du, Jin Chang, Mengmeng Xiao, Mingyu Chen, Wenjie Ying, Haoyang Lei, Xiaoming Li
{"title":"Predictions of rheumatoid arthritis burden in 204 countries and territories by 2044: based on the Global Burden of Disease Study 2021.","authors":"Wenhao Zhang, Dongmei Zhuang, Huan Lu, Ziyan Lv, Limin Huang, He Du, Jin Chang, Mengmeng Xiao, Mingyu Chen, Wenjie Ying, Haoyang Lei, Xiaoming Li","doi":"10.55563/clinexprheumatol/7dijpb","DOIUrl":"10.55563/clinexprheumatol/7dijpb","url":null,"abstract":"<p><strong>Objectives: </strong>We conducted a comprehensive analysis of the spatiotemporal dynamics of rheumatoid arthritis (RA), including age‑standardised prevalence (ASPR), incidence (ASIR), and disability‑adjusted life years (DALYs, ASDR), from 1990 to 2021, and projected trends through 2044 using data from the Global Burden of Disease (GBD) 2021 to inform and strengthen global prevention, control strategies, and public health policy for RA.</p><p><strong>Methods: </strong>ASPR, ASIR, and ASDR estimates for 204 countries and territories (1990-2021) were retrieved from GBD 2021. We quantified temporal trends by the estimated annual percentage change (EAPC) and average annual percentage change (AAPC). We examined gender‑age‑specific differences in ASPR, ASIR, and ASDR and the relationships between RA‑related DALYs and risk factors across strata. What's more, we employed AutoRegressive Integrated Moving Average (ARIMA) and the Nordpred age‑period‑cohort model to forecast prevalence and incidence through 2044. All statistical analyses were performed in R 4.4.1 and Joinpoint Trend Analysis Software.</p><p><strong>Results: </strong>Between 1990 and 2021, global ASPR and ASIR rose (AAPC: 0.44 and 0.40, respectively), while ASDR declined modestly (AAPC: -0.03). In 2021, Ireland exhibited the highest ASPR (529.08) and ASIR (35.08), whereas Mexico recorded the highest ASDR (87.45). Although higher sociodemographic index (SDI) regions bore a greater RA burden overall, lower SDI regions experienced more rapid increases. Across all metrics, women - particularly those aged ≥60 years - demonstrated higher rates than men. 'Smoking' emerged as a vital risk of DALYs across age groups, genders, and regions. Projections from Nordpred and ARIMA model indicate continued rapid growth in prevalence and incidence cases through 2044, with more gradual increases in ASPR and ASIR.</p><p><strong>Conclusions: </strong>Global prevalence and incidence of RA are projected to rise further. Detailed knowledge of these trends and their drivers is essential to inform targeted interventions and mitigate the worldwide impact of RA.</p>","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent myocarditis revealing a desmoplakin cardiomyopathy successfully treated with anakinra. 反复发作的心肌炎揭示了一种纤桥状心肌病成功地用阿那白治疗。
IF 3.4 4区 医学
Clinical and experimental rheumatology Pub Date : 2025-09-02 DOI: 10.55563/clinexprheumatol/vxe3tj
Thomas Barba, Marie Robert, Arnaud Hot
{"title":"Recurrent myocarditis revealing a desmoplakin cardiomyopathy successfully treated with anakinra.","authors":"Thomas Barba, Marie Robert, Arnaud Hot","doi":"10.55563/clinexprheumatol/vxe3tj","DOIUrl":"https://doi.org/10.55563/clinexprheumatol/vxe3tj","url":null,"abstract":"","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144945088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信